EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Endoscopic neodymium yag laser for cardiac stricture of advanced gastric cancer



Endoscopic neodymium yag laser for cardiac stricture of advanced gastric cancer



Gastroenterological Endoscopy 30(9): 1925-1936



Thirty three patients suffering from dysphagia caused by the stricture of cardiac region were treated with the Nd:YAG laser (laser group). Eighty five percent of the patients showed the improvement of the stricture, and 67% of patients showed clinical improvement of taking food and was discharged from the hospital. In order to study the quantitative and qualitative result of laser-treated patients, we picked up two non-historical control groups. One was a non-curative resection (NCR) group which consisted of 16 patients, and the other was a chemotherapy group in which there were 12 patients treated only with immunochemotherapy. As to the survival times and the lengths of time in which patients required no hospitalization (no hospitalization period), there was no difference between the laser and the NCR groups. As to characteristics of the patients, no difference was seen by the Quantification method II between the patients in both the groups as to each factor of characteristics such as age, Borrmann's type, stage of TNM, chemotherapy, complication and metastasis. On the other hand, the median survival time was 43 weeks in the laser group and 15 weeks in the chemotherapy group (p < 0.001). In addition to that, the median value of no hospitalization period was 21 weeks in the former and only one week in the latter (p < 0.01). When the patient characteristics in these two groups were compared, there were proportionally more patients having categories of Borrmann's type 4, Tegafur as chemotherapy and no distant metastasis in the laser than in the chemotherapy group. Excluding the patients with those two to three categories, there was no difference as to each factor of the characteristics between the patients in the chemotherapy group and a modified group. The median survival time became 34 weeks in the modified laser group and 15 weeks in the chemotherapy group, revealing the statistical difference (p < 0.01). We conclude that Nd:YAG laser therapy is a useful palliative treatment for improving the stricture in cardiac region of gastric cancer. It could be said that the laser treatment should be applied as the first choice to a patient who is of proof risk or whom the surgical procedure is considered to end in a non-curative resection.

(PDF emailed within 1 workday: $29.90)

Accession: 007300426

Download citation: RISBibTeXText



Related references

Endoscopic neodymium yag laser for malignant gastric stricture. Lasers in Surgery & Medicine (SUPPL 2): 26, 1990

Relief of obstruction caused by advanced esophageal and cardiac carcinoma with endoscopic neodymium-YAG laser therapy. Chinese Journal of Clinical Oncology 19(6): 444-446, 1992

Endoscopic neodymium yttrium aluminum garnet laser therapy as palliative treatment for advanced adenocarcinoma of the gastric cardia. Gastroenterology 87(4): 815-820, 1984

Endoscopic neodymium yag laser treatment for early gastric cancer using ultrasonic endoscope experimental and clinical studies on judgment of the effect after laser therapy. Gastroenterological Endoscopy 28(1): 19-31, 1986

Clinical studies of endoscopic treatment for gastric cancer by neodymium yag laser. Journal of Tokyo Women's Medical College 57(5): 329-346, 1987

Endoscopic neodymium yag laser treatment of esophageal stricture after end to end anastomosis. Journal of the Medical Society of Toho University 33(1): 99-103, 1986

Endoscopic neodymium yag laser therapy as palliative treatment for advanced cancer of the esophagus and cardia personal experience. Acta Chirurgica Italica 45(6): 1100-1106, 1989

Non surgical radical treatment of early gastric cancer by endoscopic contact neodymium yag laser report of a case. Taiwan yixuehui zazhi 89(4): 314-317, 1990

Fundamental and clinical studies of endoscopic neodymium yag laser irradiation therapy using balloon for early gastric cancer. Journal of Tokyo Medical College 49(3): 377-387, 1991

Endoscopic neodymium yag laser therapy as palliative treatment of esophageal and cardiac cancer parameters affecting long term outcome. Digestive Diseases & Sciences 35(3): 294-301, 1990

Neodymium-YAG laser alone versus neodymium-YAG plus external beam radiotherapy in advanced-stage oesophageal cancer. Spinelli, P, Dal Fante, M, Marchesini, R International Congress Series; Photodynamic therapy and biomedical lasers: 277-280, 1992

Endoscopic urethrotomy versus urethrotomy plus neodymium yag laser in the treatment of urethral stricture. European Urology 18(3): 166-168, 1990

Endoscopic neodymium-YAG laser in the palliative treatment of advanced low rectal carcinoma in Singapore. Diseases of the Colon & Rectum 34(12): 1093-1096, 1991

Clinical applications of endoscopic neodymium yag laser contact irradiation of gastric tumors. Journal of Kyoto Prefectural University of Medicine 95(4): 449-456, 1986

Factors influencing survival after endoscopic neodymium yag laser surgery for unresectable advanced malignancies of the trachea. Surgery Today (Tokyo) 22(1): 24-28, 1992